share_log

Altamira Therapeutics FY EPS $(16.47) Sales $284.47K Down From $330.37K YoY

Altamira Therapeutics FY EPS $(16.47) Sales $284.47K Down From $330.37K YoY

Altamira Therapeutics財年每股收益爲16.47美元（16.47美元）銷售額爲284.47萬美元，低於同比3.3037萬美元
Benzinga ·  04/10 21:21

Altamira Therapeutics (NASDAQ:CYTO) reported quarterly losses of $(16.47) per share. This is a 97.38 percent increase over losses of $(629.80) per share from the same period last year. The company reported $284.47 thousand in sales this quarter. This is a 13.89 percent decrease over sales of $330.37 thousand the same period last year.

Altamira Therapeutics（納斯達克股票代碼：CYTO）公佈的季度虧損爲每股16.47美元。這比去年同期每股虧損629.80美元（629.80美元）增長了97.38％。該公司報告本季度銷售額爲284,470美元。這比去年同期的330,370美元的銷售額下降了13.89％。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論